These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15243701)

  • 21. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients.
    Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M
    J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1*04, DQ8 Type 1 diabetes.
    Durinovic-Belló I; Schlosser M; Riedl M; Maisel N; Rosinger S; Kalbacher H; Deeg M; Ziegler M; Elliott J; Roep BO; Karges W; Boehm BO
    Diabetologia; 2004 Mar; 47(3):439-450. PubMed ID: 14745491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes.
    Herold KC; Brooks-Worrell B; Palmer J; Dosch HM; Peakman M; Gottlieb P; Reijonen H; Arif S; Spain LM; Thompson C; Lachin JM;
    Diabetes; 2009 Nov; 58(11):2588-95. PubMed ID: 19675135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fulminant type 1 diabetes in Australia in the absence of humoral and cellular immune responses to pancreatic islet autoantigens.
    Lee I; Harrison LC; Colman PG
    Diabetes Res Clin Pract; 2012 Jan; 95(1):e4-6. PubMed ID: 22014766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9.
    Itoh A; Shimada A; Kodama K; Morimoto J; Suzuki R; Oikawa Y; Irie J; Nakagawa Y; Shigihara T; Kanazawa Y; Okubo Y; Motohashi Y; Maruyama T; Saruta T
    Ann N Y Acad Sci; 2004 Dec; 1037():33-40. PubMed ID: 15699491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV; Fabiano de Bruno LE; Cardoso AI; Mota AH; Capucchio M; Poskus E; Fainboim L; Basabe JC
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of organ-specific autoantibodies and celiac disease--associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects.
    Jaeger C; Hatziagelaki E; Petzoldt R; Bretzel RG
    Diabetes Care; 2001 Jan; 24(1):27-32. PubMed ID: 11194235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
    Kallan AA; de Vries RR; Roep BO
    APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes.
    Gelber C; Paborsky L; Singer S; McAteer D; Tisch R; Jolicoeur C; Buelow R; McDevitt H; Fathman CG
    Diabetes; 1994 Jan; 43(1):33-9. PubMed ID: 8262314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?
    Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U
    Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes.
    Harrison LC; Honeyman MC; DeAizpurua HJ; Schmidli RS; Colman PG; Tait BD; Cram DS
    Lancet; 1993 May; 341(8857):1365-9. PubMed ID: 8098789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood.
    Roll U; Christie MR; Füchtenbusch M; Payton MA; Hawkes CJ; Ziegler AG
    Diabetes; 1996 Jul; 45(7):967-73. PubMed ID: 8666150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M; Nakamura N; Nakano K; Kondo M
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract]   [Full Text] [Related]  

  • 39. Proliferative responses to selected peptides of IA-2 in identical twins discordant for Type 1 diabetes.
    Schulz RM; Hawa M; Leslie RD; Sinigaglia F; Passini N; Rogge L; Picard JK; Londei M
    Diabetes Metab Res Rev; 2000; 16(3):150-6. PubMed ID: 10867713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets.
    Pupilli C; Giannini S; Marchetti P; Lupi R; Antonelli A; Malavasi F; Takasawa S; Okamoto H; Ferrannini E
    Diabetes; 1999 Dec; 48(12):2309-15. PubMed ID: 10580418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.